SINGAPORE, SINGAPORE, SINGAPORE, March 20, 2026 /EINPresswire.com/ -- As we navigate the sophisticated landscape of ...
Cognitive warfare technologies now model and simulate human behavior at scale, raising concerns about autonomous digital ...
Nvidia faces competition from startups developing specialised chips for AI inference as demand shifts from training large ...
Australia is emerging as a key battleground in the global race to build AI infrastructure as the sector undergoes a ... Read ...
Ovid Therapeutics advances OV329, a GABA-AT inhibitor, into Phase 2 for drug-resistant adult focal onset seizures post ...
Additional biomarker analysis reveals higher CSF levels of DOPA decarboxylase (DDC - an emerging PD biomarker) at baseline with a reduction following 90 days of dosing with GT-02287 in individuals wit ...
Nvidia introduced the DGX Station at GTC 2026, a desktop supercomputer with 20 petaflops of AI performance and 748GB of coherent memory that can run trillion-parameter AI models locally without the ...
OKYO Pharma Limited (Nasdaq: OKYO), a clinical-stage biopharmaceutical company developing investigational therapies for the treatment of neuropathic corneal pain (NCP) and for inflammatory eye ...
VITA launches VITA RING on Kickstarter, introducing a "second phase" of smart rings that shifts from passive tracking ...
Nvidia won the first round in the artificial-intelligence investment boom, but it is entering a new phase where it’s seeing a ...
Healthcare organizations are rethinking identity from the ground up, seeking to make access seamless, secure and compliant by default.